194 related articles for article (PubMed ID: 24410536)
1. Ustekinumab for the treatment of psoriatic arthritis.
Wofford J; Menter A
Expert Rev Clin Immunol; 2014 Feb; 10(2):189-202. PubMed ID: 24410536
[TBL] [Abstract][Full Text] [Related]
2. Ustekinumab: a review in the treatment of plaque psoriasis and psoriatic arthritis.
Zaghi D; Krueger GG; Callis Duffin K
J Drugs Dermatol; 2012 Feb; 11(2):160-7. PubMed ID: 22270196
[TBL] [Abstract][Full Text] [Related]
3. Ustekinumab : targeting the IL-17 pathway to improve outcomes in psoriatic arthritis.
Weitz JE; Ritchlin CT
Expert Opin Biol Ther; 2014 Apr; 14(4):515-26. PubMed ID: 24555741
[TBL] [Abstract][Full Text] [Related]
4. Ustekinumab: The "New Kid on the Block" in the Treatment of Psoriatic Arthritis.
Torres T; Faria R
Drug Dev Res; 2015 Dec; 76(8):428-31. PubMed ID: 26372543
[TBL] [Abstract][Full Text] [Related]
5. Ustekinumab associated with flares of psoriatic arthritis.
Stamell EF; Kutner A; Viola K; Cohen SR
JAMA Dermatol; 2013 Dec; 149(12):1410-3. PubMed ID: 24132520
[TBL] [Abstract][Full Text] [Related]
6. The safety of ustekinumab for the treatment of psoriatic arthritis.
López-Ferrer A; Laiz A; Puig L
Expert Opin Drug Saf; 2017 Jun; 16(6):733-742. PubMed ID: 28441904
[TBL] [Abstract][Full Text] [Related]
7. Ustekinumab: a review of its use in psoriatic arthritis.
McKeage K
Drugs; 2014 Jun; 74(9):1029-39. PubMed ID: 24919864
[TBL] [Abstract][Full Text] [Related]
8. Ustekinumab.
Cingoz O
MAbs; 2009; 1(3):216-21. PubMed ID: 20069753
[TBL] [Abstract][Full Text] [Related]
9. Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis.
Saraceno R; Bavetta M; Zangrilli A; Chiricozzi A; Potenza C; Chimenti S; Chimenti MS
Expert Opin Biol Ther; 2013 Sep; 13(9):1325-34. PubMed ID: 23930916
[TBL] [Abstract][Full Text] [Related]
10. New interleukin-23 pathway inhibitors in dermatology: ustekinumab, briakinumab, and secukinumab.
Kurzeja M; Rudnicka L; Olszewska M
Am J Clin Dermatol; 2011 Apr; 12(2):113-25. PubMed ID: 21348542
[TBL] [Abstract][Full Text] [Related]
11. New biologics for psoriasis and psoriatic arthritis.
Rozenblit M; Lebwohl M
Dermatol Ther; 2009; 22(1):56-60. PubMed ID: 19222517
[TBL] [Abstract][Full Text] [Related]
12. Treatment of psoriatic arthritis with traditional DMARD's and novel therapies: approaches and recommendations.
Maharaj AB; Chandran V
Expert Rev Clin Immunol; 2017 Apr; 13(4):319-331. PubMed ID: 27826996
[TBL] [Abstract][Full Text] [Related]
13. New treatment paradigms in psoriatic arthritis: an update on new therapeutics approved by the U.S. Food and Drug Administration.
Felquer ML; Soriano ER
Curr Opin Rheumatol; 2015 Mar; 27(2):99-106. PubMed ID: 25633241
[TBL] [Abstract][Full Text] [Related]
14. Use of brodalumab for the treatment of psoriasis and psoriatic arthritis.
Kivelevitch DN; Menter A
Immunotherapy; 2015; 7(4):323-33. PubMed ID: 25917624
[TBL] [Abstract][Full Text] [Related]
15. Long-term safety of ustekinumab for psoriasis.
Kumar N; Narang K; Cressey BD; Gottlieb AB
Expert Opin Drug Saf; 2013 Sep; 12(5):757-65. PubMed ID: 23745965
[TBL] [Abstract][Full Text] [Related]
16. Adalimumab in psoriatic arthritis.
Salvarani C; Pipitone N; Catanoso M; Chiarolanza I; Boiardi L; Caruso A; Pazzola G; Macchioni P; Di Lernia V; Albertini G
J Rheumatol Suppl; 2012 Jul; 89():77-81. PubMed ID: 22751600
[TBL] [Abstract][Full Text] [Related]
17. Development of psoriasis scalp with alopecia during treatment of Crohn's disease with infliximab and rapid response to both diseases to ustekinumab.
Andrisani G; Marzo M; Celleno L; Guidi L; Papa A; Gasbarrini A; Armuzzi A
Eur Rev Med Pharmacol Sci; 2013 Oct; 17(20):2831-6. PubMed ID: 24174369
[TBL] [Abstract][Full Text] [Related]
18. The role of IL 23 in the treatment of psoriasis.
Puig L
Expert Rev Clin Immunol; 2017 Jun; 13(6):525-534. PubMed ID: 28165883
[TBL] [Abstract][Full Text] [Related]
19. Update on ustekinumab for the treatment of Crohn's disease.
Leung Y; Panaccione R
Gastroenterol Clin North Am; 2014 Sep; 43(3):619-30. PubMed ID: 25110262
[TBL] [Abstract][Full Text] [Related]
20. Emerging drugs for psoriatic arthritis.
Caso F; Del Puente A; Peluso R; Caso P; Girolimetto N; Del Puente A; Scarpa R; Costa L
Expert Opin Emerg Drugs; 2016; 21(1):69-79. PubMed ID: 26807876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
